Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
H.C. Wainwright to hold a virtual mini-conference » 08:59
10/20/20
10/20
08:59
10/20/20
08:59
DRNA

Dicerna

$20.07 /

-0.4 (-1.95%)

, ABUS

Arbutus Biopharma

$3.01 /

-0.075 (-2.44%)

, ALNY

Alnylam

$140.59 /

-4.81 (-3.31%)

, VIR

Vir Biotechnology

$36.64 /

-2.81 (-7.12%)

, VBIV

VBI Vaccines

$2.78 /

-0.115 (-3.98%)

Hepatitis B Virus Virtual…

Hepatitis B Virus Virtual Mini-Conference 2020 will be held on October 20.

ShowHide Related Items >><<
VIR Vir Biotechnology
$36.64 /

-2.81 (-7.12%)

VBIV VBI Vaccines
$2.78 /

-0.115 (-3.98%)

DRNA Dicerna
$20.07 /

-0.4 (-1.95%)

ALNY Alnylam
$140.59 /

-4.81 (-3.31%)

ABUS Arbutus Biopharma
$3.01 /

-0.075 (-2.44%)

DRNA Dicerna
$20.07 /

-0.4 (-1.95%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
ABUS Arbutus Biopharma
$3.01 /

-0.075 (-2.44%)

09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
07/27/20 B. Riley Securities
Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR
07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
07/24/20 Baird
Arbutus Biopharma downgraded to Neutral from Outperform at Baird
ALNY Alnylam
$140.59 /

-4.81 (-3.31%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
VIR Vir Biotechnology
$36.64 /

-2.81 (-7.12%)

10/07/20 Goldman Sachs
Goldman says Lilly comments support need for multiple COVID-19 antibody makers
10/07/20 H.C. Wainwright
Vir Biotechnology price target raised to $100 from $80 at H.C. Wainwright
10/05/20
Fly Intel: Top five analyst initiations
10/05/20 BofA
Vir Biotechnology initiated with a Buy at BofA
VBIV VBI Vaccines
$2.78 /

-0.115 (-3.98%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
VIR Vir Biotechnology
$36.64 /

-2.81 (-7.12%)

DRNA Dicerna
$20.07 /

-0.4 (-1.95%)

ALNY Alnylam
$140.59 /

-4.81 (-3.31%)

ABUS Arbutus Biopharma
$3.01 /

-0.075 (-2.44%)

  • 08
    Jul
  • 22
    Apr
VIR Vir Biotechnology
$36.64 /

-2.81 (-7.12%)

VIR Vir Biotechnology
$36.64 /

-2.81 (-7.12%)

VBIV VBI Vaccines
$2.78 /

-0.115 (-3.98%)

ALNY Alnylam
$140.59 /

-4.81 (-3.31%)

ABUS Arbutus Biopharma
$3.01 /

-0.075 (-2.44%)

VBIV VBI Vaccines
$2.78 /

-0.115 (-3.98%)

ABUS Arbutus Biopharma
$3.01 /

-0.075 (-2.44%)

Over a week ago
Options
Largest borrow rate increases among liquid names » 08:45
09/28/20
09/28
08:45
09/28/20
08:45
TAN

Claymore/MAC Global Solar Energy Index

$57.64 /

+1.86 (+3.33%)

, VBIV

VBI Vaccines

$3.07 /

+0.16 (+5.50%)

, CRBP

Corbus Pharmaceuticals

$1.56 /

+0.03 (+1.96%)

, AXU

Alexco Resource

$2.59 /

-0.105 (-3.90%)

, FIZZ

National Beverage

$70.06 /

+0.23 (+0.33%)

, CF

CF Industries

$30.42 /

-0.27 (-0.88%)

, PSTI

Pluristem

$9.66 /

+0.79 (+8.91%)

, MAXR

Maxar Technologies

$24.20 /

+0.515 (+2.17%)

, ADMA

ADMA Biologics

$2.18 /

+0.135 (+6.60%)

, XERS

Xeris Pharmaceuticals

$5.75 /

+0.19 (+3.42%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Guggenheim Global Solar Index (TAN) 8.88% +3.12, VBI Vaccines (VBIV) 18.89% +2.79, Corbus Pharmaceuticals (CRBP) 85.32% +0.95, Alexco Resource (AXU) 36.23% +0.66, National Beverage (FIZZ) 1.52% +0.41, CF Industries (CF) 0.49% +0.24, Pluristem (PSTI) 40.37% +0.22, Maxar Technologies (MAXR) 0.53% +0.18, Adma Biologics (ADMA) 2.20% +0.16, and Xeris Pharmaceuticals (XERS) 47.80% +0.16.

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

AXU Alexco Resource
$2.59 /

-0.105 (-3.90%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

TAN Claymore/MAC Global Solar Energy Index
$57.64 /

+1.86 (+3.33%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 RBC Capital
Corbus Pharmaceuticals downgraded at RBC Capital after RESOLVE-1 study data
AXU Alexco Resource
$2.59 /

-0.105 (-3.90%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

05/18/20 Guggenheim
National Beverage price target raised to $38 from $34 at Guggenheim
11/18/19 Guggenheim
Coca-Cola's 'AHA' likely to take shelf space from LaCroix, says Guggenheim
11/11/19 Jefferies
National Beverage estimates and price target lowered at Jefferies
CF CF Industries
$30.42 /

-0.27 (-0.88%)

09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 HSBC
CF Industries downgraded to Hold from Buy at HSBC
09/15/20 Susquehanna
Deteriorating crop conditions positive for fertilizers, says Susquehanna
08/10/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

07/24/20 Jefferies
Pluristem price target raised to $16 from $12 at Jefferies
06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
06/19/20 Jefferies
Pluristem initiated with a Buy at Jefferies
04/24/20 H.C. Wainwright
Pluristem removed overhang with loan agreement, says H.C. Wainwright
MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

08/06/20 TD Securities
Maxar Technologies upgraded to Buy from Speculative Buy at TD Securities
06/24/20 JPMorgan
Maxar Technologies price target raised to $20 from $16 at JPMorgan
01/15/20 Credit Suisse
Maxar Technologies upgraded to Neutral from Underperform at Credit Suisse
01/08/20 JPMorgan
Maxar Technologies price target raised to $25 from $15 at JPMorgan
ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
03/16/20 H.C. Wainwright
ADMA Biologics price target lowered to $12 from $14 at H.C. Wainwright
XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

  • 26
    Jun
  • 22
    Apr
  • 25
    Mar
  • 12
    Feb
  • 07
    Feb
  • 07
    Feb
VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

MAXR Maxar Technologies
$24.20 /

+0.515 (+2.17%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

XERS Xeris Pharmaceuticals
$5.75 /

+0.19 (+3.42%)

VBIV VBI Vaccines
$3.07 /

+0.16 (+5.50%)

TAN Claymore/MAC Global Solar Energy Index
$57.64 /

+1.86 (+3.33%)

PSTI Pluristem
$9.66 /

+0.79 (+8.91%)

FIZZ National Beverage
$70.06 /

+0.23 (+0.33%)

CRBP Corbus Pharmaceuticals
$1.56 /

+0.03 (+1.96%)

CF CF Industries
$30.42 /

-0.27 (-0.88%)

AXU Alexco Resource
$2.59 /

-0.105 (-3.90%)

ADMA ADMA Biologics
$2.18 /

+0.135 (+6.60%)

Options
Largest borrow rate increases among liquid names » 08:45
09/23/20
09/23
08:45
09/23/20
08:45
BTG

B2Gold

$6.61 /

+0.085 (+1.30%)

, CRBP

Corbus Pharmaceuticals

$1.65 /

-0.075 (-4.35%)

, DX

Dynex Capital

$15.66 /

-0.04 (-0.25%)

, BLDP

Ballard Power

$16.00 /

-0.34 (-2.08%)

, BIGC

BigCommerce

$75.91 /

-0.15 (-0.20%)

, AMC

AMC Entertainment

$5.21 /

-0.115 (-2.16%)

, LMND

Lemonade

$54.08 /

+1.44 (+2.74%)

, VBIV

VBI Vaccines

$3.27 /

-0.14 (-4.11%)

, VXRT

Vaxart

$8.73 /

-0.23 (-2.57%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: B2Gold (BTG) 2.18% +1.80, Corbus Pharmaceuticals (CRBP) 14.54% +0.77, Dynex Capital (DX) 1.31% +0.64, Ballard Power (BLDP) 4.00% +0.52, BigCommerce Holdings (BIGC) 15.82% +0.33, AMC Entertainment (AMC) 104.66% +0.29, Lemonade (LMND) 14.55% +0.28, VBI Vaccines (VBIV) 1.65% +0.27, Direxion Daily Bull (TECL) 2.99% +0.27, and Vaxart (VXRT) 18.60% +0.24.

ShowHide Related Items >><<
VXRT Vaxart
$8.73 /

-0.23 (-2.57%)

VBIV VBI Vaccines
$3.27 /

-0.14 (-4.11%)

LMND Lemonade
$54.08 /

+1.44 (+2.74%)

CRBP Corbus Pharmaceuticals
$1.65 /

-0.075 (-4.35%)

BTG B2Gold
$6.61 /

+0.085 (+1.30%)

BLDP Ballard Power
$16.00 /

-0.34 (-2.08%)

BIGC BigCommerce
$75.91 /

-0.15 (-0.20%)

AMC AMC Entertainment
$5.21 /

-0.115 (-2.16%)

BTG B2Gold
$6.61 /

+0.085 (+1.30%)

08/26/20 Scotiabank
B2Gold 2020 guidance remains on track, says Scotiabank
08/19/20 RBC Capital
B2Gold shares trade at premium to peers, RBC Capital says in downgrade
08/19/20 RBC Capital
B2Gold downgraded to Sector Perform from Outperform at RBC Capital
08/10/20 BMO Capital
B2Gold price target raised to C$11.50 from C$10 at BMO Capital
CRBP Corbus Pharmaceuticals
$1.65 /

-0.075 (-4.35%)

09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 RBC Capital
Corbus Pharmaceuticals downgraded at RBC Capital after RESOLVE-1 study data
DX Dynex Capital
$15.66 /

-0.04 (-0.25%)

07/29/20 Ladenburg
Dynex Capital upgraded to Buy from Neutral at Ladenburg
01/14/20 JonesTrading
Dynex Capital initiated with a Buy at JonesTrading
11/26/19
Fly Intel: Top five analyst upgrades
11/25/19 Keefe Bruyette
Dynex Capital upgraded to Outperform from Market Perform at Keefe Bruyette
BLDP Ballard Power
$16.00 /

-0.34 (-2.08%)

08/24/20
Fly Intel: Top five analyst initiations
08/24/20 Bernstein
Bernstein starts Ballard at Outperform as pure play on hydrogen economy
08/24/20 Bernstein
Ballard Power initiated with an Outperform at Bernstein
08/21/20 Roth Capital
Roth Capital checks show 'material catalyst' is near for Ballard Power
BIGC BigCommerce
$75.91 /

-0.15 (-0.20%)

09/10/20 Truist
BigCommerce price target lowered to $100 from $132 at Truist
09/10/20 Canaccord
BigCommerce price target lowered to $90 from $125 at Canaccord
09/10/20 Barclays
BigCommerce price target lowered to $95 from $128 at Barclays
09/10/20 Morgan Stanley
BigCommerce checks 'all the boxes,' except valuation, says Morgan Stanley
AMC AMC Entertainment
$5.21 /

-0.115 (-2.16%)

09/14/20 B. Riley Securities
AMC Entertainment price target raised to $5.50 from $4 at B. Riley FBR
07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
06/30/20 Imperial Capital
AMC Entertainment price target lowered to $4 from $6 at Imperial Capital
06/29/20 Credit Suisse
Cinemark downgraded to Neutral from Outperform at Credit Suisse
LMND Lemonade
$54.08 /

+1.44 (+2.74%)

08/14/20 Morgan Stanley
Lemonade price target lowered to $70 from $91 at Morgan Stanley
07/27/20
Fly Intel: Top five analyst initiations
07/27/20 Oppenheimer
Lemonade initiated with a Perform at Oppenheimer
07/27/20 Goldman Sachs
Lemonade initiated with a Sell at Goldman Sachs
VBIV VBI Vaccines
$3.27 /

-0.14 (-4.11%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
VXRT Vaxart
$8.73 /

-0.23 (-2.57%)

09/09/20 B. Riley Securities
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
08/12/20 H.C. Wainwright
Vaxart price target raised to $17 from $7 at H.C. Wainwright
07/28/20 B. Riley Securities
Vaxart selloff on NY Times article unwarranted, says B. Riley FBR
07/13/20
Fly Intel: Top five analyst initiations
LMND Lemonade
$54.08 /

+1.44 (+2.74%)

DX Dynex Capital
$15.66 /

-0.04 (-0.25%)

CRBP Corbus Pharmaceuticals
$1.65 /

-0.075 (-4.35%)

BTG B2Gold
$6.61 /

+0.085 (+1.30%)

BLDP Ballard Power
$16.00 /

-0.34 (-2.08%)

BIGC BigCommerce
$75.91 /

-0.15 (-0.20%)

AMC AMC Entertainment
$5.21 /

-0.115 (-2.16%)

  • 05
    Aug
  • 02
    Jul
  • 22
    Apr
  • 07
    Feb
VXRT Vaxart
$8.73 /

-0.23 (-2.57%)

VBIV VBI Vaccines
$3.27 /

-0.14 (-4.11%)

BLDP Ballard Power
$16.00 /

-0.34 (-2.08%)

AMC AMC Entertainment
$5.21 /

-0.115 (-2.16%)

VXRT Vaxart
$8.73 /

-0.23 (-2.57%)

VBIV VBI Vaccines
$3.27 /

-0.14 (-4.11%)

LMND Lemonade
$54.08 /

+1.44 (+2.74%)

CRBP Corbus Pharmaceuticals
$1.65 /

-0.075 (-4.35%)

BLDP Ballard Power
$16.00 /

-0.34 (-2.08%)

BIGC BigCommerce
$75.91 /

-0.15 (-0.20%)

AMC AMC Entertainment
$5.21 /

-0.115 (-2.16%)

VXRT Vaxart
$8.73 /

-0.23 (-2.57%)

VBIV VBI Vaccines
$3.27 /

-0.14 (-4.11%)

LMND Lemonade
$54.08 /

+1.44 (+2.74%)

CRBP Corbus Pharmaceuticals
$1.65 /

-0.075 (-4.35%)

BTG B2Gold
$6.61 /

+0.085 (+1.30%)

BLDP Ballard Power
$16.00 /

-0.34 (-2.08%)

BIGC BigCommerce
$75.91 /

-0.15 (-0.20%)

AMC AMC Entertainment
$5.21 /

-0.115 (-2.16%)

Over a month ago
Conference/Events
European Association for the Study of the Liver to hold a conference » 04:55
08/29/20
08/29
04:55
08/29/20
04:55
ABBV

AbbVie

$94.19 /

-0.09 (-0.10%)

, AKRO

Akero Therapeutics

$32.27 /

+0.67 (+2.12%)

, ALBO

Albireo Pharma

$27.15 /

-0.29 (-1.06%)

, AXLA

Axcella Health

$5.07 /

-0.13 (-2.50%)

, AZN

AstraZeneca

$55.66 /

-0.445 (-0.79%)

, BMY

Bristol-Myers

$62.37 /

-0.15 (-0.24%)

, CBAY

CymaBay

$6.14 /

+ (+0.00%)

, DRRX

Durect

$1.81 /

-0.08 (-4.23%)

, ENTA

Enanta

$51.25 /

+1.25 (+2.50%)

, ETNB

89bio

$37.76 /

+0.13 (+0.35%)

, GILD

Gilead

$65.26 /

-0.32 (-0.49%)

, GLMD

Galmed

$5.08 /

+0.02 (+0.40%)

, VKTX

Viking Therapeutics

$6.84 /

-0.6 (-8.06%)

, VBIV

VBI Vaccines

$3.99 /

-0.25 (-5.90%)

, PLRX

Pliant Therapeutics

$25.37 /

+1.01 (+4.15%)

, PFE

Pfizer

$37.90 /

+0.04 (+0.11%)

, NVS

Novartis

$86.64 /

-0.37 (-0.43%)

, NVO

Novo Nordisk

$65.85 /

-0.43 (-0.65%)

, NGM

NGM Biopharmaceuticals

$17.99 /

+0.14 (+0.78%)

, MIRM

Mirum Pharmaceuticals

$24.07 /

+0.47 (+1.99%)

, MDGL

Madrigal Pharmaceuticals

$106.62 /

+0.29 (+0.27%)

, LMNL

Liminal BioSciences

$11.79 /

+0.02 (+0.17%)

, ICPT

Intercept

$49.34 /

+0.62 (+1.27%)

, GNFT

Genfit

$4.92 /

-0.03 (-0.61%)

Digital International…

Digital International Liver Congress 2020 will be held on August 27-29. Webcast Link

ShowHide Related Items >><<
VKTX Viking Therapeutics
$6.84 /

-0.6 (-8.06%)

VBIV VBI Vaccines
$3.99 /

-0.25 (-5.90%)

PFE Pfizer
$37.90 /

+0.04 (+0.11%)

NVS Novartis
$86.64 /

-0.37 (-0.43%)

NVO Novo Nordisk
$65.85 /

-0.43 (-0.65%)

NGM NGM Biopharmaceuticals
$17.99 /

+0.14 (+0.78%)

MIRM Mirum Pharmaceuticals
$24.07 /

+0.47 (+1.99%)

MDGL Madrigal Pharmaceuticals
$106.62 /

+0.29 (+0.27%)

LMNL Liminal BioSciences
$11.79 /

+0.02 (+0.17%)

ICPT Intercept
$49.34 /

+0.62 (+1.27%)

GNFT Genfit
$4.92 /

-0.03 (-0.61%)

GLMD Galmed
$5.08 /

+0.02 (+0.40%)

GILD Gilead
$65.26 /

-0.32 (-0.49%)

ETNB 89bio
$37.76 /

+0.13 (+0.35%)

ENTA Enanta
$51.25 /

+1.25 (+2.50%)

DRRX Durect
$1.81 /

-0.08 (-4.23%)

CBAY CymaBay
$6.14 /

+ (+0.00%)

BMY Bristol-Myers
$62.37 /

-0.15 (-0.24%)

AZN AstraZeneca
$55.66 /

-0.445 (-0.79%)

AXLA Axcella Health
$5.07 /

-0.13 (-2.50%)

ALBO Albireo Pharma
$27.15 /

-0.29 (-1.06%)

AKRO Akero Therapeutics
$32.27 /

+0.67 (+2.12%)

ABBV AbbVie
$94.19 /

-0.09 (-0.10%)

ABBV AbbVie
$94.19 /

-0.09 (-0.10%)

08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
08/20/20 Morgan Stanley
AbbVie price target raised to $108 from $95 at Morgan Stanley
08/19/20 Piper Sandler
AbbVie commercial efforts easier after Gilead CRL, says Piper Sandler
08/19/20 Stifel
Galapagos price target lowered to $155 from $187 at Stifel
AKRO Akero Therapeutics
$32.27 /

+0.67 (+2.12%)

08/14/20 Piper Sandler
Piper sees 89bio's topline data beating Akero's in NASH
07/23/20 BTIG
89bio initiated with a Buy at BTIG
07/20/20 H.C. Wainwright
Akero Therapeutics price target raised to $62 from $45 at H.C. Wainwright
07/07/20 Chardan
Akero Therapeutics initiated with a Buy at Chardan
ALBO Albireo Pharma
$27.15 /

-0.29 (-1.06%)

08/19/20 H.C. Wainwright
Albireo Pharma price target lowered to $50 from $64 at H.C. Wainwright
07/30/20 Piper Sandler
Albireo Pharma initiated with an Overweight at Piper Sandler
07/16/20 H.C. Wainwright
Albireo price target raised to $64 at H.C. Wainwright after BOLD trial start
06/25/20
Fly Intel: Top five analyst initiations
AXLA Axcella Health
$5.07 /

-0.13 (-2.50%)

08/05/20 Piper Sandler
Axcella reported positive hepatic insufficiency data, says Piper Sandler
07/30/20 Piper Sandler
Axcella initiated with an Overweight at Piper Sandler
05/28/20
Fly Intel: Top five analyst initiations
05/28/20 Wedbush
Wedbush bullish on Axcella, initiates with an Outperform
AZN AstraZeneca
$55.66 /

-0.445 (-0.79%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
BMY Bristol-Myers
$62.37 /

-0.15 (-0.24%)

08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
CBAY CymaBay
$6.14 /

+ (+0.00%)

08/27/20 Piper Sandler
Piper Sandler 'astonished' by seladelpar's long-term benefits
08/25/20 Citi
CymaBay price target raised to $9 from $7 at Citi
08/04/20 H.C. Wainwright
CymaBay price target raised to $13 from $9 at H.C. Wainwright
08/03/20 Cantor Fitzgerald
CymaBay price target raised to $20 from $15 at Cantor Fitzgerald
DRRX Durect
$1.81 /

-0.08 (-4.23%)

07/30/20 Oppenheimer
Durect initiated with an Outperform at Oppenheimer
07/01/20 H.C. Wainwright
Durect alcoholic hepatitis efficacy could be seen in COVID, says H.C. Wainwright
06/29/20 B. Riley Securities
Durect should be bought on weakness from Gilead termination, says B. Riley FBR
06/29/20 H.C. Wainwright
Durect thesis unchanged after Gilead termination, says H.C. Wainwright
ENTA Enanta
$51.25 /

+1.25 (+2.50%)

08/28/20
Fly Intel: Top five analyst initiations
08/27/20 Roth Capital
Enanta resumed with a Buy at Roth Capital
08/25/20 Piper Sandler
Enanta initiated with an Overweight at Piper Sandler
07/27/20 JMP Securities
Enanta upgraded to Outperform from Market Perform at JMP Securities
ETNB 89bio
$37.76 /

+0.13 (+0.35%)

07/30/20 Piper Sandler
89bio initiated with an Overweight at Piper Sandler
07/23/20
Fly Intel: Top five analyst initiations
GILD Gilead
$65.26 /

-0.32 (-0.49%)

08/20/20 Truist
Gilead price target lowered to $67 from $74 at Truist
08/19/20 Piper Sandler
Piper Sandler trims Gilead target by $2, keeps Overweight rating
08/19/20 JPMorgan
Gilead CRL for filgotinib 'near worst case scenario,' says JPMorgan
GLMD Galmed
$5.08 /

+0.02 (+0.40%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley Securities
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley Securities
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
VKTX Viking Therapeutics
$6.84 /

-0.6 (-8.06%)

08/28/20 H.C. Wainwright
Viking Therapeutics price target raised to $21 from $18 at H.C. Wainwright
06/04/20 BMO Capital
Viking Therapeutics initiated with an Outperform at BMO Capital
05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley Securities
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
VBIV VBI Vaccines
$3.99 /

-0.25 (-5.90%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
PLRX Pliant Therapeutics
$25.37 /

+1.01 (+4.15%)

08/11/20 Piper Sandler
Pliant Therapeutics' approach to fibrotic diseases best in industry, says Piper
06/29/20 Needham
Pliant Therapeutics initiated with a Buy at Needham
06/29/20 Cowen
Pliant Therapeutics initiated with an Outperform at Cowen
06/29/20 Citi
Pliant Therapeutics initiated with a Buy at Citi
PFE Pfizer
$37.90 /

+0.04 (+0.11%)

08/27/20 Chardan
Moderna vaccine showed differentiation from BioNTech/Pfizer's, says Chardan
08/25/20 Truist
Forte Biosciences initiated with a Buy at Truist
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/21/20 Mizuho
Pfizer COVID vaccine data 'ok encouraging,' says Mizuho
NVS Novartis
$86.64 /

-0.37 (-0.43%)

08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
08/12/20 JPMorgan
Novartis price target lowered to CHF 82 from CHF 84 at JPMorgan
07/28/20 Morgan Stanley
Novartis price target raised to CHF 93 from CHF 91 at Morgan Stanley
NVO Novo Nordisk
$65.85 /

-0.43 (-0.65%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NGM NGM Biopharmaceuticals
$17.99 /

+0.14 (+0.78%)

08/12/20 Piper Sandler
NGM Biopharmaceuticals' four pipeline programs underappreciated, says Piper
07/30/20 Piper Sandler
NGM Biopharmaceuticals initiated with an Overweight at Piper Sandler
07/07/20 Chardan
NGM Biopharmaceuticals initiated with a Buy at Chardan
06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
MIRM Mirum Pharmaceuticals
$24.07 /

+0.47 (+1.99%)

08/07/20 Raymond James
Mirum Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
08/07/20 Raymond James
Mirum Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
08/03/20
Fly Intel: Top five analyst initiations
08/03/20 H.C. Wainwright
Mirum Pharmaceuticals initiated with a Buy at H.C. Wainwright
MDGL Madrigal Pharmaceuticals
$106.62 /

+0.29 (+0.27%)

07/30/20 Piper Sandler
Madrigal Pharmaceuticals initiated with an Overweight at Piper Sandler
06/04/20 BMO Capital
Madrigal Pharmaceuticals initiated with a Market Perform at BMO Capital
05/22/20 B. Riley Securities
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
LMNL Liminal BioSciences
$11.79 /

+0.02 (+0.17%)

ICPT Intercept
$49.34 /

+0.62 (+1.27%)

08/28/20 Piper Sandler
Piper says Intercept data continues to tilt risk/benefit argument raised in CRL
08/10/20 Stifel
Intercept price target raised to $56 from $51 at Stifel
08/10/20 Piper Sandler
Piper Sandler confident in success of Intercept's OCA approval in 2021
GNFT Genfit
$4.92 /

-0.03 (-0.61%)

08/05/20 H.C. Wainwright
Lancet publication 'strong validation' Genfit's NIS4, says H.C. Wainwright
07/23/20 H.C. Wainwright
Genfit price target lowered to $8 from $11 at H.C. Wainwright
07/23/20
Fly Intel: Top five analyst upgrades
07/23/20 Stifel
Genfit upgraded to Buy from Hold at Stifel
VKTX Viking Therapeutics
$6.84 /

-0.6 (-8.06%)

PLRX Pliant Therapeutics
$25.37 /

+1.01 (+4.15%)

PFE Pfizer
$37.90 /

+0.04 (+0.11%)

NVS Novartis
$86.64 /

-0.37 (-0.43%)

NVO Novo Nordisk
$65.85 /

-0.43 (-0.65%)

NGM NGM Biopharmaceuticals
$17.99 /

+0.14 (+0.78%)

MIRM Mirum Pharmaceuticals
$24.07 /

+0.47 (+1.99%)

MDGL Madrigal Pharmaceuticals
$106.62 /

+0.29 (+0.27%)

ICPT Intercept
$49.34 /

+0.62 (+1.27%)

GLMD Galmed
$5.08 /

+0.02 (+0.40%)

GILD Gilead
$65.26 /

-0.32 (-0.49%)

ETNB 89bio
$37.76 /

+0.13 (+0.35%)

ENTA Enanta
$51.25 /

+1.25 (+2.50%)

DRRX Durect
$1.81 /

-0.08 (-4.23%)

CBAY CymaBay
$6.14 /

+ (+0.00%)

BMY Bristol-Myers
$62.37 /

-0.15 (-0.24%)

AZN AstraZeneca
$55.66 /

-0.445 (-0.79%)

AXLA Axcella Health
$5.07 /

-0.13 (-2.50%)

ALBO Albireo Pharma
$27.15 /

-0.29 (-1.06%)

AKRO Akero Therapeutics
$32.27 /

+0.67 (+2.12%)

ABBV AbbVie
$94.19 /

-0.09 (-0.10%)

  • 18
    Aug
  • 08
    Jul
  • 08
    Jul
  • 03
    Jun
  • 14
    May
  • 22
    Apr
  • 30
    Jan
  • 09
    Jan
  • 11
    Dec
  • 11
    Nov
  • 19
    Sep
VBIV VBI Vaccines
$3.99 /

-0.25 (-5.90%)

PFE Pfizer
$37.90 /

+0.04 (+0.11%)

NVS Novartis
$86.64 /

-0.37 (-0.43%)

NVO Novo Nordisk
$65.85 /

-0.43 (-0.65%)

GILD Gilead
$65.26 /

-0.32 (-0.49%)

BMY Bristol-Myers
$62.37 /

-0.15 (-0.24%)

AZN AstraZeneca
$55.66 /

-0.445 (-0.79%)

ABBV AbbVie
$94.19 /

-0.09 (-0.10%)

VKTX Viking Therapeutics
$6.84 /

-0.6 (-8.06%)

VBIV VBI Vaccines
$3.99 /

-0.25 (-5.90%)

PLRX Pliant Therapeutics
$25.37 /

+1.01 (+4.15%)

PFE Pfizer
$37.90 /

+0.04 (+0.11%)

NVS Novartis
$86.64 /

-0.37 (-0.43%)

NVO Novo Nordisk
$65.85 /

-0.43 (-0.65%)

NGM NGM Biopharmaceuticals
$17.99 /

+0.14 (+0.78%)

ICPT Intercept
$49.34 /

+0.62 (+1.27%)

GNFT Genfit
$4.92 /

-0.03 (-0.61%)

GILD Gilead
$65.26 /

-0.32 (-0.49%)

ETNB 89bio
$37.76 /

+0.13 (+0.35%)

DRRX Durect
$1.81 /

-0.08 (-4.23%)

CBAY CymaBay
$6.14 /

+ (+0.00%)

BMY Bristol-Myers
$62.37 /

-0.15 (-0.24%)

AZN AstraZeneca
$55.66 /

-0.445 (-0.79%)

AKRO Akero Therapeutics
$32.27 /

+0.67 (+2.12%)

ABBV AbbVie
$94.19 /

-0.09 (-0.10%)

VBIV VBI Vaccines
$3.99 /

-0.25 (-5.90%)

PFE Pfizer
$37.90 /

+0.04 (+0.11%)

NVS Novartis
$86.64 /

-0.37 (-0.43%)

NVO Novo Nordisk
$65.85 /

-0.43 (-0.65%)

NGM NGM Biopharmaceuticals
$17.99 /

+0.14 (+0.78%)

GILD Gilead
$65.26 /

-0.32 (-0.49%)

DRRX Durect
$1.81 /

-0.08 (-4.23%)

CBAY CymaBay
$6.14 /

+ (+0.00%)

BMY Bristol-Myers
$62.37 /

-0.15 (-0.24%)

AZN AstraZeneca
$55.66 /

-0.445 (-0.79%)

ABBV AbbVie
$94.19 /

-0.09 (-0.10%)

Conference/Events
European Association for the Study of the Liver to hold a conference » 09:12
08/28/20
08/28
09:12
08/28/20
09:12
ABBV

AbbVie

$94.28 /

-0.04 (-0.04%)

, AKRO

Akero Therapeutics

$31.60 /

-2.06 (-6.12%)

, ALBO

Albireo Pharma

$27.44 /

-0.84 (-2.97%)

, AXLA

Axcella Health

$5.20 /

-0.13 (-2.44%)

, AZN

AstraZeneca

$56.11 /

-0.885 (-1.55%)

, BMY

Bristol-Myers

$62.52 /

+0.23 (+0.37%)

, CBAY

CymaBay

$6.14 /

-0.33 (-5.10%)

, DRRX

Durect

$1.89 /

-0.1 (-5.03%)

, ENTA

Enanta

$50.00 /

+0.2 (+0.40%)

, ETNB

89bio

$37.63 /

-0.63 (-1.65%)

, GILD

Gilead

$65.58 /

-0.01 (-0.02%)

, GLMD

Galmed

$5.06 /

-0.08 (-1.56%)

, VKTX

Viking Therapeutics

$7.44 /

-0.67 (-8.26%)

, VBIV

VBI Vaccines

$4.24 /

+1.035 (+32.29%)

, PLRX

Pliant Therapeutics

$24.36 /

-0.27 (-1.10%)

, PFE

Pfizer

$37.86 /

-0.21 (-0.55%)

, NVS

Novartis

$87.01 /

+0.01 (+0.01%)

, NVO

Novo Nordisk

$66.28 /

-0.475 (-0.71%)

, NGM

NGM Biopharmaceuticals

$17.85 /

-0.43 (-2.35%)

, MIRM

Mirum Pharmaceuticals

$23.60 /

-0.31 (-1.30%)

, MDGL

Madrigal Pharmaceuticals

$106.33 /

+1.03 (+0.98%)

, LMNL

Liminal BioSciences

$11.77 /

-0.5 (-4.07%)

, ICPT

Intercept

$48.72 /

+0.25 (+0.52%)

, GNFT

Genfit

$4.95 /

-0.07 (-1.39%)

Digital International…

Digital International Liver Congress 2020 will be held on August 27-29. Webcast Link

ShowHide Related Items >><<
VKTX Viking Therapeutics
$7.44 /

-0.67 (-8.26%)

VBIV VBI Vaccines
$4.24 /

+1.035 (+32.29%)

PFE Pfizer
$37.86 /

-0.21 (-0.55%)

NVS Novartis
$87.01 /

+0.01 (+0.01%)

NVO Novo Nordisk
$66.28 /

-0.475 (-0.71%)

NGM NGM Biopharmaceuticals
$17.85 /

-0.43 (-2.35%)

MIRM Mirum Pharmaceuticals
$23.60 /

-0.31 (-1.30%)

MDGL Madrigal Pharmaceuticals
$106.33 /

+1.03 (+0.98%)

LMNL Liminal BioSciences
$11.77 /

-0.5 (-4.07%)

ICPT Intercept
$48.72 /

+0.25 (+0.52%)

GNFT Genfit
$4.95 /

-0.07 (-1.39%)

GLMD Galmed
$5.06 /

-0.08 (-1.56%)

GILD Gilead
$65.58 /

-0.01 (-0.02%)

ETNB 89bio
$37.63 /

-0.63 (-1.65%)

ENTA Enanta
$50.00 /

+0.2 (+0.40%)

DRRX Durect
$1.89 /

-0.1 (-5.03%)

CBAY CymaBay
$6.14 /

-0.33 (-5.10%)

BMY Bristol-Myers
$62.52 /

+0.23 (+0.37%)

AZN AstraZeneca
$56.11 /

-0.885 (-1.55%)

AXLA Axcella Health
$5.20 /

-0.13 (-2.44%)

ALBO Albireo Pharma
$27.44 /

-0.84 (-2.97%)

AKRO Akero Therapeutics
$31.60 /

-2.06 (-6.12%)

ABBV AbbVie
$94.28 /

-0.04 (-0.04%)

ABBV AbbVie
$94.28 /

-0.04 (-0.04%)

08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
08/20/20 Morgan Stanley
AbbVie price target raised to $108 from $95 at Morgan Stanley
08/19/20 Piper Sandler
AbbVie commercial efforts easier after Gilead CRL, says Piper Sandler
08/19/20 Stifel
Galapagos price target lowered to $155 from $187 at Stifel
AKRO Akero Therapeutics
$31.60 /

-2.06 (-6.12%)

08/14/20 Piper Sandler
Piper sees 89bio's topline data beating Akero's in NASH
07/23/20 BTIG
89bio initiated with a Buy at BTIG
07/20/20 H.C. Wainwright
Akero Therapeutics price target raised to $62 from $45 at H.C. Wainwright
07/07/20 Chardan
Akero Therapeutics initiated with a Buy at Chardan
ALBO Albireo Pharma
$27.44 /

-0.84 (-2.97%)

08/19/20 H.C. Wainwright
Albireo Pharma price target lowered to $50 from $64 at H.C. Wainwright
07/30/20 Piper Sandler
Albireo Pharma initiated with an Overweight at Piper Sandler
07/16/20 H.C. Wainwright
Albireo price target raised to $64 at H.C. Wainwright after BOLD trial start
06/25/20
Fly Intel: Top five analyst initiations
AXLA Axcella Health
$5.20 /

-0.13 (-2.44%)

08/05/20 Piper Sandler
Axcella reported positive hepatic insufficiency data, says Piper Sandler
07/30/20 Piper Sandler
Axcella initiated with an Overweight at Piper Sandler
05/28/20
Fly Intel: Top five analyst initiations
05/28/20 Wedbush
Wedbush bullish on Axcella, initiates with an Outperform
AZN AstraZeneca
$56.11 /

-0.885 (-1.55%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
BMY Bristol-Myers
$62.52 /

+0.23 (+0.37%)

08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
CBAY CymaBay
$6.14 /

-0.33 (-5.10%)

08/27/20 Piper Sandler
Piper Sandler 'astonished' by seladelpar's long-term benefits
08/25/20 Citi
CymaBay price target raised to $9 from $7 at Citi
08/04/20 H.C. Wainwright
CymaBay price target raised to $13 from $9 at H.C. Wainwright
08/03/20 Cantor Fitzgerald
CymaBay price target raised to $20 from $15 at Cantor Fitzgerald
DRRX Durect
$1.89 /

-0.1 (-5.03%)

07/30/20 Oppenheimer
Durect initiated with an Outperform at Oppenheimer
07/01/20 H.C. Wainwright
Durect alcoholic hepatitis efficacy could be seen in COVID, says H.C. Wainwright
06/29/20 B. Riley Securities
Durect should be bought on weakness from Gilead termination, says B. Riley FBR
06/29/20 H.C. Wainwright
Durect thesis unchanged after Gilead termination, says H.C. Wainwright
ENTA Enanta
$50.00 /

+0.2 (+0.40%)

08/27/20 Roth Capital
Enanta resumed with a Buy at Roth Capital
08/25/20 Piper Sandler
Enanta initiated with an Overweight at Piper Sandler
07/27/20 JMP Securities
Enanta upgraded to Outperform from Market Perform at JMP Securities
03/17/20 Baird
Baird upgrades 'defensive' Enanta, sees 'real COVID-19 potential'
ETNB 89bio
$37.63 /

-0.63 (-1.65%)

07/30/20 Piper Sandler
89bio initiated with an Overweight at Piper Sandler
07/23/20
Fly Intel: Top five analyst initiations
GILD Gilead
$65.58 /

-0.01 (-0.02%)

08/20/20 Truist
Gilead price target lowered to $67 from $74 at Truist
08/19/20 Piper Sandler
Piper Sandler trims Gilead target by $2, keeps Overweight rating
08/19/20 JPMorgan
Gilead CRL for filgotinib 'near worst case scenario,' says JPMorgan
GLMD Galmed
$5.06 /

-0.08 (-1.56%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley Securities
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley Securities
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
VKTX Viking Therapeutics
$7.44 /

-0.67 (-8.26%)

08/28/20 H.C. Wainwright
Viking Therapeutics price target raised to $21 from $18 at H.C. Wainwright
06/04/20 BMO Capital
Viking Therapeutics initiated with an Outperform at BMO Capital
05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley Securities
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
VBIV VBI Vaccines
$4.24 /

+1.035 (+32.29%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
PLRX Pliant Therapeutics
$24.36 /

-0.27 (-1.10%)

08/11/20 Piper Sandler
Pliant Therapeutics' approach to fibrotic diseases best in industry, says Piper
06/29/20 Needham
Pliant Therapeutics initiated with a Buy at Needham
06/29/20 Cowen
Pliant Therapeutics initiated with an Outperform at Cowen
06/29/20 Citi
Pliant Therapeutics initiated with a Buy at Citi
PFE Pfizer
$37.86 /

-0.21 (-0.55%)

08/27/20 Chardan
Moderna vaccine showed differentiation from BioNTech/Pfizer's, says Chardan
08/25/20 Truist
Forte Biosciences initiated with a Buy at Truist
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/21/20 Mizuho
Pfizer COVID vaccine data 'ok encouraging,' says Mizuho
NVS Novartis
$87.01 /

+0.01 (+0.01%)

08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
08/12/20 JPMorgan
Novartis price target lowered to CHF 82 from CHF 84 at JPMorgan
07/28/20 Morgan Stanley
Novartis price target raised to CHF 93 from CHF 91 at Morgan Stanley
NVO Novo Nordisk
$66.28 /

-0.475 (-0.71%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NGM NGM Biopharmaceuticals
$17.85 /

-0.43 (-2.35%)

08/12/20 Piper Sandler
NGM Biopharmaceuticals' four pipeline programs underappreciated, says Piper
07/30/20 Piper Sandler
NGM Biopharmaceuticals initiated with an Overweight at Piper Sandler
07/07/20 Chardan
NGM Biopharmaceuticals initiated with a Buy at Chardan
06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
MIRM Mirum Pharmaceuticals
$23.60 /

-0.31 (-1.30%)

08/07/20 Raymond James
Mirum Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
08/07/20 Raymond James
Mirum Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
08/03/20
Fly Intel: Top five analyst initiations
08/03/20 H.C. Wainwright
Mirum Pharmaceuticals initiated with a Buy at H.C. Wainwright
MDGL Madrigal Pharmaceuticals
$106.33 /

+1.03 (+0.98%)

07/30/20 Piper Sandler
Madrigal Pharmaceuticals initiated with an Overweight at Piper Sandler
06/04/20 BMO Capital
Madrigal Pharmaceuticals initiated with a Market Perform at BMO Capital
05/22/20 B. Riley Securities
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
LMNL Liminal BioSciences
$11.77 /

-0.5 (-4.07%)

ICPT Intercept
$48.72 /

+0.25 (+0.52%)

08/10/20 Stifel
Intercept price target raised to $56 from $51 at Stifel
08/10/20 Piper Sandler
Piper Sandler confident in success of Intercept's OCA approval in 2021
07/30/20 Piper Sandler
Intercept initiated with an Overweight at Piper Sandler
GNFT Genfit
$4.95 /

-0.07 (-1.39%)

08/05/20 H.C. Wainwright
Lancet publication 'strong validation' Genfit's NIS4, says H.C. Wainwright
07/23/20 H.C. Wainwright
Genfit price target lowered to $8 from $11 at H.C. Wainwright
07/23/20
Fly Intel: Top five analyst upgrades
07/23/20 Stifel
Genfit upgraded to Buy from Hold at Stifel
VKTX Viking Therapeutics
$7.44 /

-0.67 (-8.26%)

PLRX Pliant Therapeutics
$24.36 /

-0.27 (-1.10%)

PFE Pfizer
$37.86 /

-0.21 (-0.55%)

NVS Novartis
$87.01 /

+0.01 (+0.01%)

NVO Novo Nordisk
$66.28 /

-0.475 (-0.71%)

NGM NGM Biopharmaceuticals
$17.85 /

-0.43 (-2.35%)

MIRM Mirum Pharmaceuticals
$23.60 /

-0.31 (-1.30%)

MDGL Madrigal Pharmaceuticals
$106.33 /

+1.03 (+0.98%)

ICPT Intercept
$48.72 /

+0.25 (+0.52%)

GLMD Galmed
$5.06 /

-0.08 (-1.56%)

GILD Gilead
$65.58 /

-0.01 (-0.02%)

ETNB 89bio
$37.63 /

-0.63 (-1.65%)

ENTA Enanta
$50.00 /

+0.2 (+0.40%)

DRRX Durect
$1.89 /

-0.1 (-5.03%)

CBAY CymaBay
$6.14 /

-0.33 (-5.10%)

BMY Bristol-Myers
$62.52 /

+0.23 (+0.37%)

AZN AstraZeneca
$56.11 /

-0.885 (-1.55%)

AXLA Axcella Health
$5.20 /

-0.13 (-2.44%)

ALBO Albireo Pharma
$27.44 /

-0.84 (-2.97%)

AKRO Akero Therapeutics
$31.60 /

-2.06 (-6.12%)

ABBV AbbVie
$94.28 /

-0.04 (-0.04%)

  • 18
    Aug
  • 08
    Jul
  • 08
    Jul
  • 03
    Jun
  • 14
    May
  • 22
    Apr
  • 30
    Jan
  • 09
    Jan
  • 11
    Dec
  • 11
    Nov
  • 19
    Sep
VBIV VBI Vaccines
$4.24 /

+1.035 (+32.29%)

PFE Pfizer
$37.86 /

-0.21 (-0.55%)

NVS Novartis
$87.01 /

+0.01 (+0.01%)

NVO Novo Nordisk
$66.28 /

-0.475 (-0.71%)

GILD Gilead
$65.58 /

-0.01 (-0.02%)

BMY Bristol-Myers
$62.52 /

+0.23 (+0.37%)

AZN AstraZeneca
$56.11 /

-0.885 (-1.55%)

ABBV AbbVie
$94.28 /

-0.04 (-0.04%)

VKTX Viking Therapeutics
$7.44 /

-0.67 (-8.26%)

VBIV VBI Vaccines
$4.24 /

+1.035 (+32.29%)

PLRX Pliant Therapeutics
$24.36 /

-0.27 (-1.10%)

PFE Pfizer
$37.86 /

-0.21 (-0.55%)

NVS Novartis
$87.01 /

+0.01 (+0.01%)

NVO Novo Nordisk
$66.28 /

-0.475 (-0.71%)

NGM NGM Biopharmaceuticals
$17.85 /

-0.43 (-2.35%)

ICPT Intercept
$48.72 /

+0.25 (+0.52%)

GNFT Genfit
$4.95 /

-0.07 (-1.39%)

GILD Gilead
$65.58 /

-0.01 (-0.02%)

ETNB 89bio
$37.63 /

-0.63 (-1.65%)

DRRX Durect
$1.89 /

-0.1 (-5.03%)

CBAY CymaBay
$6.14 /

-0.33 (-5.10%)

BMY Bristol-Myers
$62.52 /

+0.23 (+0.37%)

AZN AstraZeneca
$56.11 /

-0.885 (-1.55%)

AKRO Akero Therapeutics
$31.60 /

-2.06 (-6.12%)

ABBV AbbVie
$94.28 /

-0.04 (-0.04%)

VBIV VBI Vaccines
$4.24 /

+1.035 (+32.29%)

PFE Pfizer
$37.86 /

-0.21 (-0.55%)

NVS Novartis
$87.01 /

+0.01 (+0.01%)

NVO Novo Nordisk
$66.28 /

-0.475 (-0.71%)

NGM NGM Biopharmaceuticals
$17.85 /

-0.43 (-2.35%)

GILD Gilead
$65.58 /

-0.01 (-0.02%)

DRRX Durect
$1.89 /

-0.1 (-5.03%)

CBAY CymaBay
$6.14 /

-0.33 (-5.10%)

BMY Bristol-Myers
$62.52 /

+0.23 (+0.37%)

AZN AstraZeneca
$56.11 /

-0.885 (-1.55%)

ABBV AbbVie
$94.28 /

-0.04 (-0.04%)

Options
Unusually active option classes on open August 27th » 09:40
08/27/20
08/27
09:40
08/27/20
09:40
VBIV

VBI Vaccines

$3.21 /

+ (+0.00%)

, ANF

Abercrombie & Fitch

$11.13 /

+ (+0.00%)

, NSC

Norfolk Southern

$213.42 /

+ (+0.00%)

, DLTR

Dollar Tree

$104.26 /

+ (+0.00%)

, BYND

Beyond Meat

$125.47 /

+ (+0.00%)

, NAK

Northern Dynasty

$0.89 /

+ (+0.00%)

, SOLO

ElectraMeccanica

$3.06 /

+ (+0.00%)

, PTON

Peloton

$67.31 /

+ (+0.00%)

, NCLH

Norwegian Cruise Line

$15.72 /

+ (+0.00%)

, AAL

American Airlines

$12.78 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Norfolk Southern (NSC), Abercrombie & Fitch (ANF), VBI Vaccines (VBIV), Dollar Tree (DLTR), Beyond Meat (BYND), Northern Dynasty (NAK), Electrameccanica Vehicles Corp (SOLO), Peloton Interactive (PTON), Norwegian Cruise Line (NCLH), and American Airlines (AAL).

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.21 /

+ (+0.00%)

SOLO ElectraMeccanica
$3.06 /

+ (+0.00%)

PTON Peloton
$67.31 /

+ (+0.00%)

NSC Norfolk Southern
$213.42 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$15.72 /

+ (+0.00%)

NAK Northern Dynasty
$0.89 /

+ (+0.00%)

DLTR Dollar Tree
$104.26 /

+ (+0.00%)

BYND Beyond Meat
$125.47 /

+ (+0.00%)

ANF Abercrombie & Fitch
$11.13 /

+ (+0.00%)

AAL American Airlines
$12.78 /

+ (+0.00%)

VBIV VBI Vaccines
$3.21 /

+ (+0.00%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
ANF Abercrombie & Fitch
$11.13 /

+ (+0.00%)

08/12/20 UBS
Abercrombie & Fitch initiated with a Neutral at UBS
05/29/20 RBC Capital
Abercrombie & Fitch price target raised to $13 from $11 at RBC Capital
04/03/20
Fly Intel: Top five analyst upgrades
04/03/20 B. Riley Securities
B. Riley FBR upgrades Abercrombie on ability to 'weather the storm'
NSC Norfolk Southern
$213.42 /

+ (+0.00%)

08/10/20 Deutsche Bank
Norfolk Southern named Catalyst Call Buy idea at Deutsche Bank
07/30/20 Wells Fargo
Norfolk Southern price target raised to $213 from $201 at Wells Fargo
07/30/20 Credit Suisse
Norfolk Southern price target raised to $216 from $199 at Credit Suisse
07/02/20
Fly Intel: Top five analyst upgrades
DLTR Dollar Tree
$104.26 /

+ (+0.00%)

08/06/20 Credit Suisse
Dollar Tree assumed with an Outperform at Credit Suisse
07/16/20 BofA
Dollar Tree upgraded to Buy from Neutral at BofA
07/16/20 BofA
Dollar Tree upgraded to Buy from Neutral at BofA
07/09/20 JPMorgan
Dollar Tree price target raised to $100 from $91 at JPMorgan
BYND Beyond Meat
$125.47 /

+ (+0.00%)

08/10/20 Goldman Sachs
Beyond Meat price target raised to $112 from $44 at Goldman Sachs
08/05/20 UBS
Beyond Meat price target raised to $110 from $105 at UBS
08/05/20 Piper Sandler
Piper calls Beyond Meat the Tesla of packaged food, ups price target
07/28/20
Fly Intel: Top five analyst initiations
NAK Northern Dynasty
$0.89 /

+ (+0.00%)

07/28/20 BMO Capital
Northern Dynasty price target raised to C$3.50 from C$1.50 at BMO Capital
06/29/20 TD Securities
Northern Dynasty price target raised to C$2.25 from C$1.30 at TD Securities
05/14/20 TD Securities
Northern Dynasty price target raised to C$1.30 from C$0.75 at TD Securities
SOLO ElectraMeccanica
$3.06 /

+ (+0.00%)

04/03/20 Benchmark
ElectraMeccanica downgraded to Speculative Hold at Benchmark
09/18/19 Aegis
ElectraMeccanica initiated with a Buy at Aegis
PTON Peloton
$67.31 /

+ (+0.00%)

08/27/20 Goldman Sachs
Goldman says expectations for Peloton 'far too low,' ups price target to $96
08/14/20 Stifel
Peloton price target raised to $72 from $62 at Stifel
08/13/20 Cowen
Apple potential service not likely to threaten Peloton leadership, says Cowen
08/11/20 Rosenblatt
Nautilus' strong trends a positive for Peloton, says Rosenblatt
NCLH Norwegian Cruise Line
$15.72 /

+ (+0.00%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 Truist
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 Truist
Norwegian Cruise Line downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Norwegian Cruise Line downgraded to Neutral from Outperform at Macquarie
AAL American Airlines
$12.78 /

+ (+0.00%)

07/28/20 Citi
Citi cuts American Airlines target to $11, opens negative catalyst watch
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Raymond James
American Airlines upgraded at Raymond James on balanced risk-reward
07/27/20 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
SOLO ElectraMeccanica
$3.06 /

+ (+0.00%)

PTON Peloton
$67.31 /

+ (+0.00%)

NSC Norfolk Southern
$213.42 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$15.72 /

+ (+0.00%)

DLTR Dollar Tree
$104.26 /

+ (+0.00%)

BYND Beyond Meat
$125.47 /

+ (+0.00%)

ANF Abercrombie & Fitch
$11.13 /

+ (+0.00%)

AAL American Airlines
$12.78 /

+ (+0.00%)

  • 17
    Jul
  • 23
    Jun
  • 11
    May
  • 06
    May
  • 22
    Apr
  • 19
    Sep
  • 26
    Sep
VBIV VBI Vaccines
$3.21 /

+ (+0.00%)

PTON Peloton
$67.31 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$15.72 /

+ (+0.00%)

DLTR Dollar Tree
$104.26 /

+ (+0.00%)

BYND Beyond Meat
$125.47 /

+ (+0.00%)

ANF Abercrombie & Fitch
$11.13 /

+ (+0.00%)

AAL American Airlines
$12.78 /

+ (+0.00%)

VBIV VBI Vaccines
$3.21 /

+ (+0.00%)

PTON Peloton
$67.31 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$15.72 /

+ (+0.00%)

DLTR Dollar Tree
$104.26 /

+ (+0.00%)

BYND Beyond Meat
$125.47 /

+ (+0.00%)

ANF Abercrombie & Fitch
$11.13 /

+ (+0.00%)

AAL American Airlines
$12.78 /

+ (+0.00%)

SOLO ElectraMeccanica
$3.06 /

+ (+0.00%)

PTON Peloton
$67.31 /

+ (+0.00%)

NCLH Norwegian Cruise Line
$15.72 /

+ (+0.00%)

NAK Northern Dynasty
$0.89 /

+ (+0.00%)

DLTR Dollar Tree
$104.26 /

+ (+0.00%)

BYND Beyond Meat
$125.47 /

+ (+0.00%)

ANF Abercrombie & Fitch
$11.13 /

+ (+0.00%)

AAL American Airlines
$12.78 /

+ (+0.00%)

On The Fly
Wall Street analyst says VBI Vaccines may have 'best' COVID vaccine of all » 09:34
08/27/20
08/27
09:34
08/27/20
09:34
VBIV

VBI Vaccines

$3.21 /

-0.07 (-2.14%)

, DKS

Dick's Sporting

$53.98 /

+7.33 (+15.71%)

, GRWG

GrowGeneration

$14.10 /

-0.82 (-5.50%)

, PTON

Peloton

$67.31 /

+0.75 (+1.13%)

, PSNL

Personalis

$21.87 /

+0.73 (+3.45%)

Check out today's top…

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

PTON Peloton
$67.31 /

+0.75 (+1.13%)

PSNL Personalis
$21.87 /

+0.73 (+3.45%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

DKS Dick's Sporting
$53.98 /

+7.33 (+15.71%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
DKS Dick's Sporting
$53.98 /

+7.33 (+15.71%)

08/27/20
Fly Intel: Top five analyst downgrades
08/27/20
Fly Intel: Top five analyst upgrades
08/27/20 DA Davidson
Dick's Sporting price target raised to $67 from $57 at DA Davidson
08/27/20 Stifel
Dick's Sporting price target raised to $62 from $34 at Stifel
GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

08/27/20
Fly Intel: Top five analyst initiations
08/26/20 Stifel
GrowGeneration initiated with a Buy at Stifel
08/13/20 Alliance Global Partners
GrowGeneration price target raised to $17 from $10 at Alliance Global Partners
07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
PTON Peloton
$67.31 /

+0.75 (+1.13%)

08/27/20 Goldman Sachs
Goldman says expectations for Peloton 'far too low,' ups price target to $96
08/14/20 Stifel
Peloton price target raised to $72 from $62 at Stifel
08/13/20 Cowen
Apple potential service not likely to threaten Peloton leadership, says Cowen
08/11/20 Rosenblatt
Nautilus' strong trends a positive for Peloton, says Rosenblatt
PSNL Personalis
$21.87 /

+0.73 (+3.45%)

08/27/20 H.C. Wainwright
Personalis initiated with a Buy at H.C. Wainwright
08/18/20 Needham
Personalis initiated with a Buy at Needham
08/17/20 Needham
Personalis initiated with a Buy at Needham
11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
PTON Peloton
$67.31 /

+0.75 (+1.13%)

PSNL Personalis
$21.87 /

+0.73 (+3.45%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

DKS Dick's Sporting
$53.98 /

+7.33 (+15.71%)

  • 12
    Aug
  • 30
    Jun
  • 22
    Apr
  • 19
    Sep
  • 26
    Sep
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

PTON Peloton
$67.31 /

+0.75 (+1.13%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

DKS Dick's Sporting
$53.98 /

+7.33 (+15.71%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

PTON Peloton
$67.31 /

+0.75 (+1.13%)

PSNL Personalis
$21.87 /

+0.73 (+3.45%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

DKS Dick's Sporting
$53.98 /

+7.33 (+15.71%)

PTON Peloton
$67.31 /

+0.75 (+1.13%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

DKS Dick's Sporting
$53.98 /

+7.33 (+15.71%)

Upgrade
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James » 08:24
08/27/20
08/27
08:24
08/27/20
08:24
VBIV

VBI Vaccines

$3.21 /

-0.07 (-2.14%)

Raymond James analyst…

Raymond James analyst Steven Seedhouse upgraded VBI Vaccines to Strong Buy from Outperform with a price target of $9, up from $8, following first look data for VBI's COVID-19 vaccine. Seedhouse tells investors in a research note that the vaccine looks like it could be the best vaccine of them all, including all of the first movers and Operation Warp Speed members.

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
03/31/20 BMO Capital
VBI Vaccines COVID-19 program represents upside to estimates, says BMO Capital
  • 22
    Apr
  • 19
    Sep
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

Recommendations
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer » 07:23
08/27/20
08/27
07:23
08/27/20
07:23
VBIV

VBI Vaccines

$3.21 /

-0.07 (-2.14%)

Oppenheimer analyst…

Oppenheimer analyst Leland Gershell believes VBI Vaccines' coronavirus vaccine has the potential to be best-in-class in a crowded arena and looks ahead to an initiation of Phase 1/2 trial around the end of the year. The analyst made no change to his Outperform rating or $8 price target.

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
03/31/20 BMO Capital
VBI Vaccines COVID-19 program represents upside to estimates, says BMO Capital
11/14/19 Raymond James
VBI Vaccines initiated with an Outperform at Raymond James
  • 22
    Apr
  • 19
    Sep
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

On The Fly
Fly Intel: After-Hours Movers » 19:16
08/26/20
08/26
19:16
08/26/20
19:16
NTAP

NetApp

$42.24 /

+0.445 (+1.06%)

, BOX

Box

$19.30 /

+1.26 (+6.98%)

, ESTC

Elastic

$112.96 /

+8.855 (+8.51%)

, VBIV

VBI Vaccines

$3.21 /

-0.07 (-2.14%)

, GRWG

GrowGeneration

$14.10 /

-0.82 (-5.50%)

, ABT

Abbott

$103.20 /

+0.72 (+0.70%)

, AMC

AMC Entertainment

$5.60 /

+0.06 (+1.08%)

, WSM

Williams-Sonoma

$98.98 /

+3.645 (+3.82%)

, GEF

Greif

$39.46 /

+0.57 (+1.47%)

, LCI

Lannett

$6.05 /

-0.125 (-2.02%)

, SMTC

Semtech

$62.95 /

+0.23 (+0.37%)

, SPLK

Splunk

$216.72 /

+13.17 (+6.47%)

, PAHC

Phibro Animal Health

$20.32 /

-0.15 (-0.73%)

, AEYE

AudioEye

$18.91 /

-0.69 (-3.52%)

Check out this evening's…

ShowHide Related Items >><<
WSM Williams-Sonoma
$98.98 /

+3.645 (+3.82%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

SPLK Splunk
$216.72 /

+13.17 (+6.47%)

SMTC Semtech
$62.95 /

+0.23 (+0.37%)

PAHC Phibro Animal Health
$20.32 /

-0.15 (-0.73%)

NTAP NetApp
$42.24 /

+0.445 (+1.06%)

LCI Lannett
$6.05 /

-0.125 (-2.02%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

GEF Greif
$39.46 /

+0.57 (+1.47%)

ESTC Elastic
$112.96 /

+8.855 (+8.51%)

BOX Box
$19.30 /

+1.26 (+6.98%)

AMC AMC Entertainment
$5.60 /

+0.06 (+1.08%)

AEYE AudioEye
$18.91 /

-0.69 (-3.52%)

ABT Abbott
$103.20 /

+0.72 (+0.70%)

NTAP NetApp
$42.24 /

+0.445 (+1.06%)

08/25/20 JPMorgan
NetApp assumed with a Neutral at JPMorgan
06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
BOX Box
$19.30 /

+1.26 (+6.98%)

05/28/20 Raymond James
Box price target raised to $24 from $18 at Raymond James
05/28/20 Craig-Hallum
Box upgraded to Buy at Craig-Hallum on improved execution, net expansion
05/28/20 Wells Fargo
Box price target raised to $25 from $20 at Wells Fargo
05/28/20 Oppenheimer
Box price target raised to $22 from $16 at Oppenheimer
ESTC Elastic
$112.96 /

+8.855 (+8.51%)

08/24/20 Barclays
Elastic price target raised to $120 from $108 at Barclays
08/21/20 RBC Capital
Elastic price target raised to $111 from $95 at RBC Capital
08/20/20
Fly Intel: Top five analyst upgrades
08/20/20 Citi
Elastic upgraded to Buy from Neutral at Citi
VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
03/31/20 BMO Capital
VBI Vaccines COVID-19 program represents upside to estimates, says BMO Capital
11/14/19 Raymond James
VBI Vaccines initiated with an Outperform at Raymond James
GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

08/26/20 Stifel
GrowGeneration initiated with a Buy at Stifel
08/13/20 Alliance Global Partners
GrowGeneration price target raised to $17 from $10 at Alliance Global Partners
07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
ABT Abbott
$103.20 /

+0.72 (+0.70%)

07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
07/23/20 Argus
Abbott price target raised to $125 from $110 at Argus
07/17/20 B. Riley Securities
B. Riley FBR starts ClearPoint at Buy, sees potential takeover
07/14/20 Cowen
Edwards Lifesciences patent settlement removes overhang, says Cowen
AMC AMC Entertainment
$5.60 /

+0.06 (+1.08%)

07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
06/30/20 Imperial Capital
AMC Entertainment price target lowered to $4 from $6 at Imperial Capital
06/29/20 Credit Suisse
Cinemark downgraded to Neutral from Outperform at Credit Suisse
06/29/20 Credit Suisse
AMC Entertainment downgraded to Underperform from Neutral at Credit Suisse
WSM Williams-Sonoma
$98.98 /

+3.645 (+3.82%)

08/25/20 RBC Capital
Williams-Sonoma price target raised to $99 from $76 at RBC Capital
08/24/20 JPMorgan
Williams-Sonoma price target raised to $89 from $75 at JPMorgan
08/21/20
Fly Intel: Top five analyst upgrades
08/21/20 Gordon Haskett
Gordon Haskett says Williams-Sonoma 'deserves more respect' in upgrade to Buy
GEF Greif
$39.46 /

+0.57 (+1.47%)

03/02/20 BMO Capital
Greif price target lowered to $32 from $36 at BMO Capital
02/13/20 BofA
Paused project a positive for containerboard market, says BofA
01/14/20
Fly Intel: Top five analyst upgrades
01/14/20 Wells Fargo
Greif upgraded to Overweight from Equal Weight at Wells Fargo
LCI Lannett
$6.05 /

-0.125 (-2.02%)

07/10/20 Raymond James
Raymond James lowers Lannett forecasts on fluphenazine competition
09/18/19 Truist
Lannett price target raised to $14 from $10 at SunTrust
08/29/19 Truist
Lannett price target raised to $10 from $7 at SunTrust
SMTC Semtech
$62.95 /

+0.23 (+0.37%)

08/21/20 Oppenheimer
Semtech price target raised to $65 from $60 at Oppenheimer
08/18/20 Piper Sandler
Semtech price target raised to $70 from $63 at Piper Sandler
05/28/20 Needham
Semtech price target raised to $65 from $47 at Needham
05/28/20 Loop Capital
Semtech price target raised to $61 from $46 at Loop Capital
SPLK Splunk
$216.72 /

+13.17 (+6.47%)

08/21/20
Loop Capital starts Splunk with a Buy on wider use of its IT solutions
08/21/20 RBC Capital
Splunk price target raised to $210 from $190 at RBC Capital
08/20/20 Loop Capital
Splunk initiated with a Buy at Loop Capital
08/19/20 Mizuho
Splunk price target raised to $205 from $195 at Mizuho
PAHC Phibro Animal Health
$20.32 /

-0.15 (-0.73%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
AEYE AudioEye
$18.91 /

-0.69 (-3.52%)

05/15/20 B. Riley Securities
AudioEye price target raised to $14.50 from $11.50 at B. Riley FBR
10/24/19 National Securities
AudioEye resumed with a Buy at National Securities
WSM Williams-Sonoma
$98.98 /

+3.645 (+3.82%)

SPLK Splunk
$216.72 /

+13.17 (+6.47%)

SMTC Semtech
$62.95 /

+0.23 (+0.37%)

PAHC Phibro Animal Health
$20.32 /

-0.15 (-0.73%)

NTAP NetApp
$42.24 /

+0.445 (+1.06%)

LCI Lannett
$6.05 /

-0.125 (-2.02%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

GEF Greif
$39.46 /

+0.57 (+1.47%)

ESTC Elastic
$112.96 /

+8.855 (+8.51%)

BOX Box
$19.30 /

+1.26 (+6.98%)

AMC AMC Entertainment
$5.60 /

+0.06 (+1.08%)

AEYE AudioEye
$18.91 /

-0.69 (-3.52%)

ABT Abbott
$103.20 /

+0.72 (+0.70%)

  • 27
    Aug
  • 30
    Jun
  • 22
    Apr
  • 19
    Sep
WSM Williams-Sonoma
$98.98 /

+3.645 (+3.82%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

NTAP NetApp
$42.24 /

+0.445 (+1.06%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

BOX Box
$19.30 /

+1.26 (+6.98%)

AMC AMC Entertainment
$5.60 /

+0.06 (+1.08%)

ABT Abbott
$103.20 /

+0.72 (+0.70%)

WSM Williams-Sonoma
$98.98 /

+3.645 (+3.82%)

VBIV VBI Vaccines
$3.21 /

-0.07 (-2.14%)

SPLK Splunk
$216.72 /

+13.17 (+6.47%)

NTAP NetApp
$42.24 /

+0.445 (+1.06%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

ESTC Elastic
$112.96 /

+8.855 (+8.51%)

BOX Box
$19.30 /

+1.26 (+6.98%)

AMC AMC Entertainment
$5.60 /

+0.06 (+1.08%)

AEYE AudioEye
$18.91 /

-0.69 (-3.52%)

ABT Abbott
$103.20 /

+0.72 (+0.70%)

WSM Williams-Sonoma
$98.98 /

+3.645 (+3.82%)

SPLK Splunk
$216.72 /

+13.17 (+6.47%)

NTAP NetApp
$42.24 /

+0.445 (+1.06%)

GRWG GrowGeneration
$14.10 /

-0.82 (-5.50%)

ESTC Elastic
$112.96 /

+8.855 (+8.51%)

BOX Box
$19.30 /

+1.26 (+6.98%)

AMC AMC Entertainment
$5.60 /

+0.06 (+1.08%)

ABT Abbott
$103.20 /

+0.72 (+0.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.